Dose finding of oncolytic combination therapy: Essential to secure the patient's quality of life.

Wuyts, Stephanie C; Schoffelen, Rafke; Westdorp, Harm; van Erp, Nielka P

Wuyts, Stephanie C; Schoffelen, Rafke; Westdorp, Harm; van Erp, Nielka P.

Afiliación

Wuyts SC; Department of Pharmacology and Toxicology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands; Research Group Clinical Pharmacology and Clinical Pharmacy, Centre for Pharmaceutical Research, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel
Schoffelen R; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands. Electronic address: rafke.schoffelen@radboudumc.nl.
Westdorp H; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands. Electronic address: harm.w
van Erp NP; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands. Electronic address: nielka.vanerp@radboudumc.nl.

Eur J Cancer ; 162: 237-240, 2022 02.

Article en En | MEDLINE | ID: mdl-34420835

Asunto(s)

Viroterapia Oncolítica; Calidad de Vida; Terapia Combinada; Humanos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Calidad de Vida / Viroterapia Oncolítica Tipo de estudio: Diagnostic_studies Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Eur J Cancer Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google